ID   AUXI_HUMAN              Reviewed;         913 AA.
AC   O75061; B7Z3V8; D3DQ65; D3DQ66; Q32M66; Q4G0K1; Q5T614; Q5T615;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2006, sequence version 3.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=Putative tyrosine-protein phosphatase auxilin {ECO:0000305};
DE            EC=3.1.3.48;
DE   AltName: Full=DnaJ homolog subfamily C member 6 {ECO:0000312|HGNC:HGNC:15469};
GN   Name=DNAJC6 {ECO:0000312|HGNC:HGNC:15469};
GN   Synonyms=KIAA0473 {ECO:0000312|EMBL:BAA32318.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries
RT   from human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563 AND SER-570, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   INVOLVEMENT IN PARK19A.
RX   PubMed=22563501; DOI=10.1371/journal.pone.0036458;
RA   Edvardson S., Cinnamon Y., Ta-Shma A., Shaag A., Yim Y.I., Zenvirt S.,
RA   Jalas C., Lesage S., Brice A., Taraboulos A., Kaestner K.H.,
RA   Greene L.E., Elpeleg O.;
RT   "A deleterious mutation in DNAJC6 encoding the neuronal-specific
RT   clathrin-uncoating co-chaperone auxilin, is associated with juvenile
RT   parkinsonism.";
RL   PLoS ONE 7:E36458-E36458(2012).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORMS 3 AND 4), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112 AND SER-570, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   TISSUE SPECIFICITY, AND INVOLVEMENT IN PARK19A.
RX   PubMed=23211418; DOI=10.1016/j.parkreldis.2012.11.006;
RA   Koroglu C., Baysal L., Cetinkaya M., Karasoy H., Tolun A.;
RT   "DNAJC6 is responsible for juvenile parkinsonism with phenotypic
RT   variability.";
RL   Parkinsonism Relat. Disord. 19:320-324(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   INVOLVEMENT IN PARK19B, VARIANT PARK19B GLY-870, VARIANTS LEU-76;
RP   PRO-152; VAL-264; SER-441 AND CYS-562, AND CHARACTERIZATION OF VARIANT
RP   PARK19B GLY-870.
RX   PubMed=26528954; DOI=10.1002/ana.24553;
RG   International Parkinsonism Genetics Network;
RA   Olgiati S., Quadri M., Fang M., Rood J.P., Saute J.A., Chien H.F.,
RA   Bouwkamp C.G., Graafland J., Minneboo M., Breedveld G.J., Zhang J.,
RA   Verheijen F.W., Boon A.J., Kievit A.J., Jardim L.B., Mandemakers W.,
RA   Barbosa E.R., Rieder C.R., Leenders K.L., Wang J., Bonifati V.;
RT   "DNAJC6 mutations associated with early-onset Parkinson's disease.";
RL   Ann. Neurol. 79:244-256(2016).
RN   [14]
RP   INVOLVEMENT IN PARK19A.
RX   PubMed=26703368; DOI=10.1002/ana.24591;
RA   Elsayed L.E., Drouet V., Usenko T., Mohammed I.N., Hamed A.A.,
RA   Elseed M.A., Salih M.A., Koko M.E., Mohamed A.Y., Siddig R.A.,
RA   Elbashir M.I., Ibrahim M.E., Durr A., Stevanin G., Lesage S.,
RA   Ahmed A.E., Brice A.;
RT   "A novel nonsense mutation in DNAJC6 expands the phenotype of
RT   autosomal-recessive juvenile-onset Parkinson's disease.";
RL   Ann. Neurol. 79:335-337(2016).
CC   -!- FUNCTION: Recruits HSPA8/HSC70 to clathrin-coated vesicles and
CC       promotes uncoating of clathrin-coated vesicles. Plays a role in
CC       clathrin-mediated endocytosis in neurons (By similarity).
CC       {ECO:0000250|UniProtKB:Q80TZ3}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate.
CC   -!- SUBUNIT: Interacts with HSPA8/HSC70. Interacts with CLTC.
CC       Interacts with AP2A2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q27974}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O75061-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75061-2; Sequence=VSP_019580;
CC       Name=3;
CC         IsoId=O75061-3; Sequence=VSP_019579, VSP_019581;
CC         Note=Contains a N-acetylmethionine at position 1.
CC         {ECO:0000244|PubMed:22814378};
CC       Name=4;
CC         IsoId=O75061-4; Sequence=VSP_019579;
CC         Note=No experimental confirmation available. Contains a
CC         N-acetylmethionine at position 1. {ECO:0000244|PubMed:22814378};
CC   -!- TISSUE SPECIFICITY: Expressed in various brain regions, including
CC       cerebellum, corpus callosum, cortex, striatum, brainstem, pons,
CC       putamen, spinal cord and substantia nigra. Very low expression in
CC       non-neural tissues such as leukocytes, liver, adipose tissue,
CC       skeletal muscle and bone marrow. {ECO:0000269|PubMed:23211418}.
CC   -!- DISEASE: Parkinson disease 19A, juvenile-onset (PARK19A)
CC       [MIM:615528]: A juvenile form of Parkinson disease, a complex
CC       neurodegenerative disorder characterized by bradykinesia, resting
CC       tremor, muscular rigidity and postural instability, as well as by
CC       a clinically significant response to treatment with levodopa. The
CC       pathology involves the loss of dopaminergic neurons in the
CC       substantia nigra and the presence of Lewy bodies (intraneuronal
CC       accumulations of aggregated proteins), in surviving neurons in
CC       various areas of the brain. PARK19A is characterized by onset of
CC       parkinsonian symptoms in the first or second decade of life. Some
CC       patients may have additional neurologic features, including mental
CC       retardation and seizures. {ECO:0000269|PubMed:22563501,
CC       ECO:0000269|PubMed:23211418, ECO:0000269|PubMed:26703368}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Parkinson disease 19B, early-onset (PARK19B)
CC       [MIM:615528]: An early-onset form of Parkinson disease, a complex
CC       neurodegenerative disorder characterized by bradykinesia, resting
CC       tremor, muscular rigidity and postural instability, as well as by
CC       a clinically significant response to treatment with levodopa. The
CC       pathology involves the loss of dopaminergic neurons in the
CC       substantia nigra and the presence of Lewy bodies (intraneuronal
CC       accumulations of aggregated proteins), in surviving neurons in
CC       various areas of the brain. PARK19B is characterized by symptoms
CC       onset in the third-to-fifth decade, slow disease progression, and
CC       prominent. response to dopaminergic therapies. Inheritance is
CC       autosomal recessive. {ECO:0000269|PubMed:26528954}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA32318.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB007942; BAA32318.2; ALT_INIT; mRNA.
DR   EMBL; AK296408; BAH12344.1; -; mRNA.
DR   EMBL; AL139294; CAI18997.1; -; Genomic_DNA.
DR   EMBL; AL355487; CAI18997.1; JOINED; Genomic_DNA.
DR   EMBL; AC119800; CAI18997.1; JOINED; Genomic_DNA.
DR   EMBL; AL139294; CAI18999.1; -; Genomic_DNA.
DR   EMBL; AL355487; CAI18999.1; JOINED; Genomic_DNA.
DR   EMBL; AC119800; CAI18999.1; JOINED; Genomic_DNA.
DR   EMBL; AL355487; CAI23547.1; -; Genomic_DNA.
DR   EMBL; AC119800; CAI23547.1; JOINED; Genomic_DNA.
DR   EMBL; AL139294; CAI23547.1; JOINED; Genomic_DNA.
DR   EMBL; AL355487; CAI23548.1; -; Genomic_DNA.
DR   EMBL; AC119800; CAI23548.1; JOINED; Genomic_DNA.
DR   EMBL; AL139294; CAI23548.1; JOINED; Genomic_DNA.
DR   EMBL; AL356212; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06533.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06534.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06536.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06537.1; -; Genomic_DNA.
DR   EMBL; BC051722; AAH51722.1; -; mRNA.
DR   EMBL; BC109279; AAI09280.2; -; mRNA.
DR   EMBL; BC109280; AAI09281.2; -; mRNA.
DR   CCDS; CCDS30739.1; -. [O75061-1]
DR   CCDS; CCDS58004.1; -. [O75061-2]
DR   CCDS; CCDS58005.1; -. [O75061-4]
DR   RefSeq; NP_001243793.1; NM_001256864.1. [O75061-2]
DR   RefSeq; NP_001243794.1; NM_001256865.1. [O75061-4]
DR   RefSeq; NP_055602.1; NM_014787.3. [O75061-1]
DR   UniGene; Hs.647643; -.
DR   ProteinModelPortal; O75061; -.
DR   SMR; O75061; -.
DR   BioGrid; 115167; 9.
DR   IntAct; O75061; 6.
DR   MINT; MINT-2797206; -.
DR   STRING; 9606.ENSP00000378735; -.
DR   DEPOD; O75061; -.
DR   iPTMnet; O75061; -.
DR   PhosphoSitePlus; O75061; -.
DR   BioMuta; DNAJC6; -.
DR   MaxQB; O75061; -.
DR   PaxDb; O75061; -.
DR   PeptideAtlas; O75061; -.
DR   PRIDE; O75061; -.
DR   Ensembl; ENST00000263441; ENSP00000263441; ENSG00000116675. [O75061-4]
DR   Ensembl; ENST00000371069; ENSP00000360108; ENSG00000116675. [O75061-2]
DR   Ensembl; ENST00000395325; ENSP00000378735; ENSG00000116675. [O75061-1]
DR   GeneID; 9829; -.
DR   KEGG; hsa:9829; -.
DR   UCSC; uc001dcd.3; human. [O75061-1]
DR   CTD; 9829; -.
DR   DisGeNET; 9829; -.
DR   GeneCards; DNAJC6; -.
DR   HGNC; HGNC:15469; DNAJC6.
DR   HPA; HPA031182; -.
DR   HPA; HPA054917; -.
DR   MalaCards; DNAJC6; -.
DR   MIM; 608375; gene.
DR   MIM; 615528; phenotype.
DR   neXtProt; NX_O75061; -.
DR   OpenTargets; ENSG00000116675; -.
DR   Orphanet; 391411; Atypical juvenile parkinsonism.
DR   PharmGKB; PA27423; -.
DR   eggNOG; KOG0431; Eukaryota.
DR   eggNOG; KOG2283; Eukaryota.
DR   eggNOG; ENOG41129H2; LUCA.
DR   GeneTree; ENSGT00870000136426; -.
DR   HOGENOM; HOG000034235; -.
DR   HOVERGEN; HBG004322; -.
DR   InParanoid; O75061; -.
DR   KO; K09526; -.
DR   OMA; IPPDNPR; -.
DR   OrthoDB; EOG091G06HJ; -.
DR   PhylomeDB; O75061; -.
DR   TreeFam; TF105165; -.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   ChiTaRS; DNAJC6; human.
DR   GeneWiki; Auxilin; -.
DR   GenomeRNAi; 9829; -.
DR   PRO; PR:O75061; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116675; -.
DR   CleanEx; HS_DNAJC6; -.
DR   ExpressionAtlas; O75061; baseline and differential.
DR   Genevisible; O75061; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; IBA:GO_Central.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IBA:GO_Central.
DR   GO; GO:2000369; P:regulation of clathrin-dependent endocytosis; IEA:Ensembl.
DR   GO; GO:0016191; P:synaptic vesicle uncoating; ISS:BHF-UCL.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR014020; Tensin_C2-dom.
DR   InterPro; IPR029023; Tensin_phosphatase.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF10409; PTEN_C2; 1.
DR   SMART; SM00271; DnaJ; 1.
DR   SMART; SM01326; PTEN_C2; 1.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS51182; C2_TENSIN; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
DR   PROSITE; PS51181; PPASE_TENSIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chaperone; Complete proteome;
KW   Disease mutation; Hydrolase; Neurodegeneration; Parkinson disease;
KW   Parkinsonism; Phosphoprotein; Polymorphism; Protein phosphatase;
KW   Reference proteome; Repeat; SH3-binding.
FT   CHAIN         1    913       Putative tyrosine-protein phosphatase
FT                                auxilin.
FT                                /FTId=PRO_0000244516.
FT   REPEAT       36     39       1.
FT   REPEAT       40     43       2.
FT   REPEAT       44     47       3.
FT   DOMAIN       55    222       Phosphatase tensin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00590}.
FT   DOMAIN      228    366       C2 tensin-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00589}.
FT   DOMAIN      849    913       J. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00286}.
FT   REGION       36     47       3 X 4 AA approximate tandem repeats.
FT   MOTIF       409    417       SH3-binding. {ECO:0000255}.
FT   COMPBIAS    466    760       Pro-rich.
FT   COMPBIAS    529    532       Poly-Gly.
FT   ACT_SITE    164    164       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00590}.
FT   MOD_RES     112    112       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     453    453       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q80TZ3}.
FT   MOD_RES     456    456       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q80TZ3}.
FT   MOD_RES     563    563       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     570    570       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     13       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_019579.
FT   VAR_SEQ       1      7       MKDSENK -> MSLLGSYRKKTSNDGYESLQLVDSNGDLSA
FT                                GSGGVGGKQRVNAGAAARSPARQPPDRASTMDSS (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_019580.
FT   VAR_SEQ     456    913       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_019581.
FT   VARIANT      76     76       M -> L (in dbSNP:rs61757223).
FT                                {ECO:0000269|PubMed:26528954}.
FT                                /FTId=VAR_077924.
FT   VARIANT     152    152       L -> P. {ECO:0000269|PubMed:26528954}.
FT                                /FTId=VAR_077925.
FT   VARIANT     264    264       I -> V. {ECO:0000269|PubMed:26528954}.
FT                                /FTId=VAR_077926.
FT   VARIANT     441    441       C -> S (in dbSNP:rs145329294).
FT                                {ECO:0000269|PubMed:26528954}.
FT                                /FTId=VAR_077927.
FT   VARIANT     562    562       R -> C (in dbSNP:rs770127313).
FT                                {ECO:0000269|PubMed:26528954}.
FT                                /FTId=VAR_077928.
FT   VARIANT     671    671       S -> N (in dbSNP:rs4915691).
FT                                /FTId=VAR_026908.
FT   VARIANT     870    870       R -> G (in PARK19B; patient fibroblasts
FT                                show decreased levels of the protein).
FT                                {ECO:0000269|PubMed:26528954}.
FT                                /FTId=VAR_077929.
FT   CONFLICT    178    178       M -> V (in Ref. 2; BAH12344).
FT                                {ECO:0000305}.
FT   CONFLICT    425    425       F -> S (in Ref. 5; AAH51722).
FT                                {ECO:0000305}.
SQ   SEQUENCE   913 AA;  99997 MW;  7B7187AAC8ADF2E4 CRC64;
     MKDSENKGAS SPDMEPSYGG GLFDMVKGGA GRLFSNLKDN LKDTLKDTSS RVIQSVTSYT
     KGDLDFTYVT SRIIVMSFPL DNVDIGFRNQ VDDIRSFLDS RHLDHYTVYN LSPKSYRTAK
     FHSRVSECSW PIRQAPSLHN LFAVCRNMYN WLLQNPKNVC VVHCLDGRAA SSILVGAMFI
     FCNLYSTPGP AIRLLYAKRP GIGLSPSHRR YLGYMCDLLA DKPYRPHFKP LTIKSITVSP
     IPFFNKQRNG CRPYCDVLIG ETKIYSTCTD FERMKEYRVQ DGKIFIPLNI TVQGDVVVSM
     YHLRSTIGSR LQAKVTNTQI FQLQFHTGFI PLDTTVLKFT KPELDACDVP EKYPQLFQVT
     LDVELQPHDK VIDLTPPWEH YCTKDVNPSI LFSSHQEHQD TLALGGQAPI DIPPDNPRHY
     GQSGFFASLC WQDQKSEKSF CEEDHAALVN QESEQSDDEL LTLSSPHGNA NGDKPHGVKK
     PSKKQQEPAA PPPPEDVDLL GLEGSAMSNS FSPPAAPPTN SELLSDLFGG GGAAGPTQAG
     QSGVEDVFHP SGPASTQSTP RRSATSTSAS PTLRVGEGAT FDPFGAPSKP SGQDLLGSFL
     NTSSASSDPF LQPTRSPSPT VHASSTPAVN IQPDVSGGWD WHAKPGGFGM GSKSAATSPT
     GSSHGTPTHQ SKPQTLDPFA DLGTLGSSSF ASKPTTPTGL GGGFPPLSSP QKASPQPMGG
     GWQQGGAYNW QQPQPKPQPS MPHSSPQNRP NYNVSFSAMP GGQNERGKGS SNLEGKQKAA
     DFEDLLSGQG FNAHKDKKGP RTIAEMRKEE MAKEMDPEKL KILEWIEGKE RNIRALLSTM
     HTVLWAGETK WKPVGMADLV TPEQVKKVYR KAVLVVHPDK ATGQPYEQYA KMIFMELNDA
     WSEFENQGQK PLY
//
